SCHEMBL6049566

SCHEMBL6049566

CC(C)(C)c1cc(N(C(N)=O)c2ccc(Cc3ccncc3)cc2)[nH]n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.43
ERBB2 P04626 1/20 0.43
MAPK11 Q15759 1/20 0.43
CYP17A1 P05093 3/20 0.39
TSHR P16473 2/20 0.39
HPGD P15428 2/20 0.39
RAF1 P04049 1/20 0.36
POLB P06746 2/20 0.35
LMNA P02545 2/20 0.35
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MEN1 O00255 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
CCNC P24863 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3629208 0.84 RAF1 (0.43) MAPK14RAF1
SCHEMBL6049496 0.84 MAPK14 (0.43) MAPK14MAPK11CCNCCDK8
SCHEMBL27842253 0.76 MAPK14 (0.54) MAPK14ERBB2MAPK11CYP17A1TSHR
SCHEMBL3630939 0.76 RAF1 (0.38) MAPK14RAF1
SCHEMBL27608860 0.76 CYP17A1 (0.49) CYP17A1TSHRHPGDPOLBLMNA
SCHEMBL6049499 0.74 PTK2 (0.34) SMN1; SMN2CCNCCDK8
SCHEMBL3630059 0.74 CYP17A1 (0.39) MAPK14ERBB2MAPK11CYP17A1TSHR
SCHEMBL27608792 0.73 CYP17A1 (0.49) CYP17A1TSHRHPGDPOLBLMNA
SCHEMBL27608750 0.71 ESR1 (0.47) CYP17A1TSHRHPGDPOLBLMNA
SCHEMBL13388916 0.70 MEN1 (0.47) CYP17A1POLBLMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1041982-A4 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS BAYER PHARMACEUTICALS CORP (US) 2006-06-14 EP disclosed
EP-1041982-A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS Bayer Corporation (US) 2000-10-11 EP disclosed
WO-1999032111-A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS BAYER CORPORATION (US) 1999-07-01 WO disclosed